PYC Therapeutics Ltd
ASX:PYC
PYC Therapeutics Ltd
ASX:PYC
Price:
0.105 AUD
5%
Market Closed
Updated:
Jun 1, 2024
PYC Therapeutics Ltd
Total Receivables
|
PYC Therapeutics Ltd
Total Receivables Peer Comparison
Comparables:
IMM
MSB
CSL
CUV
TLX
Competitive Total Receivables Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Total Receivables | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
PYC Therapeutics Ltd
ASX:PYC
|
Total Receivables
AU$8.7m
|
CAGR 3-Years
344%
|
CAGR 5-Years
120%
|
CAGR 10-Years
14%
|
|
|
Immutep Ltd
ASX:IMM
|
Total Receivables
AU$6.1m
|
CAGR 3-Years
5%
|
CAGR 5-Years
11%
|
CAGR 10-Years
12%
|
|
|
Mesoblast Ltd
ASX:MSB
|
Total Receivables
$4m
|
CAGR 3-Years
6%
|
CAGR 5-Years
2%
|
CAGR 10-Years
N/A
|
|
|
CSL Ltd
ASX:CSL
|
Total Receivables
$3.6B
|
CAGR 3-Years
20%
|
CAGR 5-Years
11%
|
CAGR 10-Years
14%
|
|
|
Clinuvel Pharmaceuticals Ltd
ASX:CUV
|
Total Receivables
AU$13.1m
|
CAGR 3-Years
39%
|
CAGR 5-Years
66%
|
CAGR 10-Years
25%
|
|
|
Telix Pharmaceuticals Ltd
ASX:TLX
|
Total Receivables
AU$71.9m
|
CAGR 3-Years
72%
|
CAGR 5-Years
53%
|
CAGR 10-Years
N/A
|
See Also
What is PYC Therapeutics Ltd's Total Receivables?
Total Receivables
8.7m
AUD
8.7m
AUD
Based on the financial report for Dec 31, 2023, PYC Therapeutics Ltd's Total Receivables amounts to 8.7m AUD.
What is PYC Therapeutics Ltd's Total Receivables growth rate?
Total Receivables CAGR 10Y
14%
14%
Over the last year, the Total Receivables growth was 0%. The average annual Total Receivables growth rates for PYC Therapeutics Ltd have been 344% over the past three years , 120% over the past five years , and 14% over the past ten years .
You don't have any saved screeners yet
